SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-124695
Filing Date
2021-04-21
Accepted
2021-04-21 16:10:59
Documents
6
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d23837ddef14a.htm DEF 14A 345875
2 GRAPHIC g23837dsp38a.jpg GRAPHIC 6555
3 GRAPHIC g23837dsp38b.jpg GRAPHIC 2638
4 GRAPHIC g23837dsp38c.jpg GRAPHIC 2280
5 GRAPHIC g23837dsp39.jpg GRAPHIC 1917
6 GRAPHIC g23837g22a44.jpg GRAPHIC 35074
  Complete submission text file 0001193125-21-124695.txt   414372
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39103 | Film No.: 21841652
SIC: 2836 Biological Products, (No Diagnostic Substances)